Zheng H - Search Results

1

Identification of genetic associations between acute myocardial infarction and non-small cell lung cancer.

Zheng H, Wang J, Zheng Y, Hong X, Wang L. Zheng H, et al. Among authors: zheng y. Front Mol Biosci. 2024 Dec 6;11:1502509. doi: 10.3389/fmolb.2024.1502509. eCollection 2024. Front Mol Biosci. 2024. PMID: 39712244 Free PMC article.

2

MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.

Zhang G, Zheng H, Zhang G, Cheng R, Lu C, Guo Y, Zhao G. Zhang G, et al. Among authors: zheng h. Cancer Cell Int. 2017 Apr 17;17:46. doi: 10.1186/s12935-017-0415-9. eCollection 2017. Cancer Cell Int. 2017. PMID: 28428733 Free PMC article.

3

Osimertinib in the Treatment of EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.

Pan J, Cai X, Cao Z, Pan J, Zheng H. Pan J, et al. Among authors: zheng h. Pharmacology. 2023;108(1):8-16. doi: 10.1159/000527321. Epub 2022 Dec 5. Pharmacology. 2023. PMID: 36470213 Free article.

4

Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non-small cell lung cancer: A meta-analysis.

Pan J, Bian Y, Cao Z, Lei L, Pan J, Huang J, Cai X, Lan X, Zheng H. Pan J, et al. Among authors: zheng h. Thorac Cancer. 2020 Feb;11(2):329-335. doi: 10.1111/1759-7714.13265. Epub 2019 Dec 17. Thorac Cancer. 2020. PMID: 31846184 Free PMC article.

5

Anti-PD1 or anti-PD-L1 antibodies alone or in combination with chemotherapy first-line treatment of advanced non-small cell lung cancer.

Zhang X, Cai X, Zheng H. Zhang X, et al. Among authors: zheng h. Thorac Cancer. 2022 Apr;13(7):1104-1105. doi: 10.1111/1759-7714.14358. Epub 2022 Feb 24. Thorac Cancer. 2022. PMID: 35199960 Free PMC article. No abstract available.

6

CBX8 Promotes Epithelial-mesenchymal Transition, Migration, and Invasion of Lung Cancer through Wnt/β-catenin Signaling Pathway.

Cai X, Lv Y, Pan J, Cao Z, Zhang J, Li Y, Zheng H. Cai X, et al. Among authors: zheng h. Curr Protein Pept Sci. 2024;25(5):386-393. doi: 10.2174/0113892037273375231204080906. Curr Protein Pept Sci. 2024. PMID: 38265409

7

XRCC1 rs1799782 Promotes DNA Damage Repair in Lung Cancer Cells by Enhancing Its Binding to FOXA1 to Facilitate FOXA1-Mediated Transcription of XRCC1.

Xu C, Li Y, Pan J, Wang S, Ye Z, Cai X, Zheng H, Yin Z, Cao Z. Xu C, et al. Among authors: zheng h. Discov Med. 2024 Jan;36(180):82-90. doi: 10.24976/Discov.Med.202436180.7. Discov Med. 2024. PMID: 38273748

8

Inhibitory Effect of Immunologically Activated Mesenchymal Stem Cells on Lung Cancer Cell Growth and Metastasis.

Ye H, Pan J, Gong E, Cai X, Xu C, Li Y, Zheng H, Cao Z. Ye H, et al. Among authors: zheng h. Cancer Biother Radiopharm. 2023 Jun;38(5):322-335. doi: 10.1089/cbr.2020.3855. Epub 2021 Mar 26. Cancer Biother Radiopharm. 2023. PMID: 33769841

9

Luteolin suppresses lung cancer progression through targeting the circ_0000190/miR-130a-3p/notch-1 signaling pathway.

Zheng H, Zhu X, Gong E, Lv Y, Li Y, Cai X. Zheng H, et al. J Chemother. 2023 Jul;35(4):330-342. doi: 10.1080/1120009X.2022.2102303. Epub 2022 Aug 9. J Chemother. 2023. PMID: 35943044

10

Ganoderic acid A suppresses autophagy by regulating the circFLNA/miR-486-3p/CYP1A1/XRCC1 axis to strengthen the sensitivity of lung cancer cells to cisplatin.

Gong E, Pan J, Ye Z, Cai X, Zheng H, Yin Z, Jiang Y, Wang X, Cao Z. Gong E, et al. Among authors: zheng h. J Pharm Pharmacol. 2024 Apr 3;76(4):354-367. doi: 10.1093/jpp/rgad116. J Pharm Pharmacol. 2024. PMID: 38330446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,035 results

Search Page

Filters